FEATURED

Digital Vaccine Manufacturing Facility, Sanofi, Singapore
Sanofi revealed on April 12, 2021, that it will spend €400 million over five years in Singapore to build a
DEALS

Sanofi Acquires Tidal Therapeutics and its Novel mRNA-based Research Platform
French pharma giant Sanofi is set to acquire Tidal Therapeutics for $470m, adding the biotech’s novel mRNA-based research platform with
PRESS RELEASES

Ectica to Present at CHI Conference on Targeting Stromal Cells in Cancer
Ectica Technologies is delighted to announce it will be presenting as a corporate sponsor at the upcoming CHI Conference on
Comments & Analysis

The Acceleration of Digitalisation in Pharma in 2020
This year, more than ever has required the pharma industry to dive into digitalisation in all shapes and forms. With
RESOURCES
Download the latest pharmaceutical case studies, white papers, research papers and product brochures

Advanced ceramic heaters benefits for analytical equipment
How advanced ceramic heaters offer more design flexibility for mass spectrometers and other pieces of analytical equipment A WATLOW White
LATEST PROJECTS

Digital Vaccine Manufacturing Facility, Sanofi, Singapore
Sanofi revealed on April 12, 2021, that it will spend €400 million over five years in Singapore to build a
CLINICAL TRIALS

BMY’s Neoadjuvant Opdivo Plus Chemotherapy Significantly Improves pCR for Resectable NSCLC in Phase 3 Trial
Bristol Myers Squibb announced positive results from a Phase 3 Trial, which showed that neoadjuvant treatment with three cycles of
REGULATORY

EU Authorizes Teva’s Seffalair® Spiromax® and BroPair® Spiromax®
Teva Pharmaceuticals Europe reported that Seffalair Spiromax and its duplicate BroPair Spiromax (salmeterol xinafoate/fluticasone propionate, 12.75/100 and 12.75/202 micrograms administered